My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Apple Passes Less Inflation to iPhone Buyers...
Oracle's $664 Billion Backlog Is Finally Star...
Morgan Stanley Sees $80 Billion Tesla Semi Op...
Meta Courts European Bond Investors to Help B...
Michigan Consumer Sentiment Drops To Second-L...
Sam Altman Weighs AI Slowdown as Bridgewater...
Eli Lilly Utilizes Weight-Loss Drug Profits T...
Oracle Says Its AI Buildout Will Pay for Itse...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    RECURSION PHARMACEUTICALS INC (NASDAQ: RXRX)

    Overview
    current price
    $3.20
    $3.20
    change
    0.04 | 1.27%
    0.04 | 1.27%
    Yesterday's Close
    3.16
    open
    3.21
    volume
    8.03 M
    30d. avg volume.
    15.16 M
    1 day
    3.15 - 3.25
    52 weeks
    2.77 - 7.18
    p/e
    0.00
    beta
    1.0756
    market cap
    1.71 B
    dividend yield
    0.00%
    Industry
    -
    RXRX by TradingView
    News and Commentary
    Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI While corporate America is becoming more selective about using artificial intelligence as a rationale for acquisitions, Anthropic is making its biggest bet yet that AI will resha...
    Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'Th... Alphabet Inc.'s (GOOG&...
    Nvidia's AI Revolution Is Transforming Healthcare with Johnson & Johnson and GE Healthcare Partnersh... Last week, Nvidia Corp (NVDA
    Nvidia Bolsters AI Leadership with Investment in Arm Holdings, Eyes Future Growth in Semiconductor I... Nvidia Corp (NVDA&nbsp...
    AI Integration In Biotech & Pharma: Companies Positioned To Benefit The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug dis...
    Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential It's not unusual to see relatively new, unprofitable biotech stocks soaring on potential, particularly after promising clinical trial results.But some s...
    Market Update: Stocks Rise Higher as June CPI Cools Stocks rose higher Wednesday as fresh inflation data pointed to cooling price pressures, raising market sentiment that the Federal Reserve can bring down inflation without causin...
    Coinbase's Direct Listing Comes Alongside Hot IPO Week The initial public offering (IPO) market picked back up last week with nine traditional IPOs raising $5.4 billion alongside Coinbase's blockbuster direct listing.
    StockTwits
    StockTwits
    Most Shared
    Dollar Tree Says Higher Fuel Prices Are Becoming a ‘Very, Very Meaningful’ Headwind
    Apple iPhone Duo Starts at $1,999 With 7.6-Inch Foldable Display: AAPL CEO John Ternus Says No More ‘Two Phones Awkwardly Stuck Together’
    AI's Half-Trillion-Dollar Borrowing Binge Is Competing With Uncle Sam for Bond Buyers
    Most Popular
    AI's Half-Trillion-Dollar Borrowing Binge Is Competing With Uncle Sam for Bond Buyers
    Fed September Hike Odds Spike to 59% After Warsh’s Hawkish Jackson Hole Speech
    Alibaba Stock Falls 7% on Profit Miss, but Analyst Stays Bullish on AI Cloud
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Microsoft
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?